1 - 4 out of 4Page size: 10
  1. 2024

  2. CML-612 The Role of NK-Cells in Resistance CML Patients to TKI

    Khordzhasov, L., Chitanava, T., Vlasik, R., Kulemina, O., Ataman, A., Luchkina, N., Aronov, A., Matvienko, Y., Siordiya, N., Lazorko, N., Sbityakova, E., Shnalieva, N., Tochenaya, E., Alekseeva, Y., Butylin, P., Smirnov, S., Shatilova, A. & Lomaia, E., 1 Sep 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, S377.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  3. The Role of NK Cells in CML Patients Resistant to TKI

    Khordzhasov, L., Chitanava, T., Vlasik, R., Kulemina, O., Ataman, A., Luchkina, N., Aronov, A., Matvienko, Y., Siordiya, N., Lazorko, N., Sbityakova, E., Shnalieva, N., Tochenaya, E., Alekseeva, Y., Butylin, P., Smirnov, S., Shatilova, A. & Lomaia, E., 1 Sep 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, S189.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  4. 2023

  5. CML-480 The Clonality of Myeloid-Derived Suppressor Cells in Chronic Myeloid Leukemia Patients

    Kulemina, O., Chitanava, T., Vlasik, R., Khordzhasov, L., Nikulina, T., Merzlikina, O., Mirolubova, Y., Tolstopyatova, E., Solovyev, V., Shnalieva, N., Butylin, P., Luchkina, N., Ataman, A., Aronov, A. & Lomaia, E., 1 Sep 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, p. S344

    Research output: Contribution to journal › Article › peer-review

  6. 2015

  7. Efficacy of Tyrosine Kinase Inhibitors in Third Line Therapy in Chronic Phase Chronic Myeloid Leukemia

    Lomaia, E., Zaritskey, A., Shuvaev, V., Martynkevich, I., Fominykh, M., Ovsyannikova, E., Lazorko, N., Matyuhina, N., Butylin, P., Machyulaitene, E., Salamatova, E. & Abdulkadyrov, K., 3 Dec 2015, In: Blood. 126, 23, p. 4051-4051 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

ID: 51992872